Atıf İçin Kopyala
Yorgun H., CANPOLAT U., Kaya E. B., Aytemir K., Oto A.
TEXAS HEART INSTITUTE JOURNAL, cilt.38, sa.4, ss.427-430, 2011 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
38
Sayı:
4
-
Basım Tarihi:
2011
-
Dergi Adı:
TEXAS HEART INSTITUTE JOURNAL
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.427-430
-
Anahtar Kelimeler:
Anticoagulants/therapeutic use, blood coagulation/drug effects, echocardiography, transesophageal, heart catheterization/adverse effects, heart septal defects, atrial/blood/therapy, heparin/therapeutic use, prosthesis implantation/adverse effects/instrumentation, septal occluder device, thrombosis/drug therapy/etiology/prevention & control/ultrasonography, treatment outcome, PATENT FORAMEN OVALE, TRANSCATHETER CLOSURE, PLATELET, DEVICE, ACTIVATION
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Percutaneous closure of an ostium secundum-type atrial septal defect is typically a safe and effective therapeutic option in the presence of significant shunting or paradoxical embolism. Infrequently, however, periprocedural sequelae occur.